Strs Ohio Nuvalent, Inc. Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in Nuvalent, Inc. stock. As of the latest transaction made, Strs Ohio holds 7,000 shares of NUVL stock, worth $631,260. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,000

Previous 7,500 6.67%

Holding current value

$631,260

Previous $568,000 26.06%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$67.44 - $112.17 $33,720 - $56,085	-500 Reduced 6.67%	7,000 $716,000
Q2 2024 Aug 05, 2024	BUY	$62.76 - $81.61 $50,208 - $65,288	800 Added 11.94%	7,500 $568,000
Q1 2024 May 13, 2024	SELL	$72.35 - $88.99 $28,939 - $35,596	-400 Reduced 5.63%	6,700 $503,000
Q4 2023 Jan 30, 2024	BUY	$42.42 - $80.28 $135,744 - $256,896	3,200 Added 82.05%	7,100 $522,000
Q3 2023 Oct 26, 2023	SELL	$39.12 - $49.85 $266,016 - $338,980	-6,800 Reduced 63.55%	3,900 $179,000
Q2 2023 Jul 31, 2023	SELL	$23.58 - $44.68 $35,370 - $67,020	-1,500 Reduced 12.3%	10,700 $451,000
Q1 2023 Aug 02, 2023	BUY	$25.42 - $33.52 $38,130 - $50,280	1,500 Added 14.02%	12,200 $318,000
Q4 2022 Jan 26, 2023	BUY	$18.46 - $36.37 $225,212 - $443,713	12,200 New	12,200 $363,000
Q2 2022 Jul 25, 2022	SELL	$7.4 - $15.07 $31,820 - $64,801	-4,300 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$11.65 - $19.57 $20,970 - $35,226	1,800 Added 72.0%	4,300 $59,000
Q3 2021 Oct 22, 2021	BUY	$18.25 - $38.35 $45,625 - $95,875	2,500 New	2,500 $56,000

Others Institutions Holding NUVL

# of Institutions

207

Shares Held

59.5M

Call Options Held

269K

Put Options Held

490K

View Full List

About Nuvalent, Inc.

Ticker NUVL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,977,800
Market Cap $3.88B
Description
Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...

More about NUVL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account